AEM Early Access 77: Survival by Time-to-Administration of Amiodarone, Lidocaine, or Placebo in Shock- Refractory Out-of-Hospital Cardiac Arrest

<p>Amiodarone and lidocaine have not been shown to have a clear survival benefit<br /> compared to placebo for out-of-hospital cardiac arrest (OHCA). However, randomized trials may  have been impacted by delayed administration of the study drugs. Today we’re talking with Dr. Joshua Lupton, first author on a new AEM paper entitled “ Survival by Time-to-Administration of Amiodarone, Lidocaine, or Placebo in Shock-Refractory Out-of-Hospital Cardiac Arrest.”  </p>